RxDoctor Payments Data

Anjali Saqi, MD

Clinical Pathology/Laboratory Medicine · New York, NYNPI 1881640605

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $167,589 of the $181,580 with a category attached, or 92.3%. Genentech, Inc. accounts for 71.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $53,103 and has fallen 74.0% since, to $13,818 in 2025. Among clinical pathology/laboratory medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,580in general payments, 2019–2025

Across 69 payments — averaging $2631.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$131K
  • AbbVie$29K
  • E.r. Squibb & Sons, L.L.C.$12K
  • F. Hoffmann-la Roche AG$7K
  • Gilead$3K
  • Genentech USA, Inc.$433
  • plus $62 from 2 others
$1,322,570in research payments, 2019–2025

Across 12 payments — averaging $110,214 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$1.3M
  • F. Hoffmann-la Roche AG$1K

What the payments were for

  • Consulting fees$167,58992%
  • Travel & lodging$12,4607%
  • Food & beverage$1,5311%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$181,580 in reported general payments places this provider in the 95th percentile of 37 clinical pathology/laboratory medicine providers in New York.

See all clinical pathology/laboratory medicine providers in New York

Medicare billing

Part B allowed, 2024
$94,602
Medicare patients
349
Services billed
2,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →